Skip to content

Evaluation of the effect of oral product of silk (Bombyx mori L. Cocoon), on sexual dysfunction and Quality of Life in women of reproductive age

Evaluation of the effect of oral traditional Persian medicine product of silk (Bombyx mori L. Cocoon), on sexual dysfunction and Quality of Life in women of reproductive age, compare with placebo. a triple-blind randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221017056213N1
Enrollment
74
Registered
2022-12-04
Start date
2022-11-22
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual dysfunction. Sexual dysfunction not due to a substance or known physiological condition

Interventions

Intervention 1: Intervention group: Patients will be given traditional Persian medicine products containing silk. Silk syrup is taken three times a day for 3 weeks and 10 cc each time. Intervention 2:

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Women aged 18-50 years The woman being married and her husband being monogamous FSFI women's sexual function index score<28 in the initial evaluation Ability to read, understand and complete the questionnaire People with BMI less than 30 Having informed consent to enter the study

Exclusion criteria

Exclusion criteria: pregnancy and breastfeeding delaying menstruation for 2 months or more significant clinical findings in physical examination, screening tests or other findings that prevent safe participation in the study, including the presence of any organic, anatomical disease (such as malformation of the anatomy of the external genitalia, spinal cord injuries or related surgery), hormonal in the study group such as diabetes, cerebrovascular disease, liver and kidney function damage, heart disease, hypothyroidism, cancers in history and medical history of psychiatric diseases that are under drug treatment. receiving psychotherapy or other treatments for sexual dysfunction using tobacco, alcohol, drug abuse using any chemical and herbal medicine known to affect libido being participate in another clinical trial study major changes in recent relationships, ongoing or unforeseeable disorder or disturbance that is not related to his sexual dysfunction.

Design outcomes

Primary

MeasureTime frame
Sexual dysfunction. Timepoint: The beginning of the study, the end of the fourth week from the beginning of the intervention, one month after the end of the intervention. Method of measurement: female sexual function index Questionnaire.;Quality of Life. Timepoint: The beginning and end of the study. Method of measurement: Quality of life questionnaire with 36 questions.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactfatemeh jahani

Ghoum University of Medical Sciences

fatima.jahani1370@gmail.com00982537764073-4

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026